Docetaxel plus oral metronomic cyclophosphamide: A phase II study with pharmacodynamic and pharmacogenetic analyses in castration-resistant prostate cancer patients

By  

Cancer, Vol. 120, Iss. 24, 2014-12 ,pp. : 3923-3931

Blackwell Publishing

Access to resources Recommend Favorite

A phase I pharmacokinetic and pharmacodynamic study of CKD-732, an antiangiogenic agent, in patients with refractory solid cancer

By Shin Sang   Jeung Hei-Cheul   Ahn Joong   Rha Sun   Roh Jae   Park Kyung   Kim Dal-Hyun   Kim Chin   Chung Hyun  

Investigational New Drugs, Vol. 28, Iss. 5, 2010-10 ,pp. : 650-658

Springer Publishing Company

Access to resources Recommend Favorite

A Pharmacokinetic and Pharmacodynamic Study of Oral Oxycodone in a Human Experimental Pain Model of Hyperalgesia

By Olesen Anne E.   Upton Richard  

Clinical Pharmacokinetics, Vol. 49, Iss. 12, 2010-12 ,pp. : 817-827

Adis International

Access to resources Recommend Favorite

Phase I safety, pharmacokinetic and pharmacodynamic studies of 2-methoxyestradiol alone or in combination with docetaxel in patients with locally recurrent or metastatic breast cancer

By James Jehana   Murry Daryl   Treston Anthony   Storniolo Anna   Sledge George   Sidor Carolyn   Miller Kathy  

Investigational New Drugs, Vol. 25, Iss. 1, 2007-02 ,pp. : 41-48

Springer Publishing Company

Access to resources Recommend Favorite

Optimization of voriconazole dosage regimen to improve the efficacy in patients with invasive fungal disease by pharmacokinetic/pharmacodynamic analysis

By  

Fundamental & Clinical Pharmacology, Vol. 30, Iss. 5, 2016-10 ,pp. : 459-465

John Wiley & Sons Inc

Access to resources Recommend Favorite